Global Immunotherapy Drugs Market Growth, Share, Size, Trends and Forecast (2022 - 2028)
Segmented by Drug Type;
Monoclonal Antibodies and Adult Vaccines - Preventive Vaccines and Therapeutic Vaccines, Checkpoint Inhibitors , Interferons Alpha & Beta , Interleukins and Other Drugs.Segmented by Therapy Area;
Cancer , Autoimmune and Inflammatory Diseases , Infectious Diseases and Other Therapy Areas.Segmented by End User;
Hospitals , Clinics and Other End Users.Segmented by Geography;
North America, Europe, Asia Pacific, Middle East and Africa and Latin America - Report Timeline (2018 - 2028).Introduction
Global Immunotherapy Drugs Market (USD Million), 2018 - 2028
# | Global |
---|---|
2018 | 76.1 |
2019 | 87.1 |
2020 | 89.1 |
2021 | 104.8 |
2022 | 107.6 |
2023 | 107.9 |
2024 | 127.1 |
2025 | 148.7 |
2026 | 172.2 |
2027 | 182.8 |
2028 | 200.8 |
In the year 2021, the Global Immunotherapy Drugs Market was valued at USD 147,243.15 million. The size of this market is expected to increase to USD 300,913.20 million by the year 2028, while growing at a Compounded Annual Growth Rate (CAGR) of 10.8%.
Global Immunotherapy Drugs Market Report Snapshot
Parameters | Description |
---|---|
Market | Global Immunotherapy Drugs Market |
Study Period | 2018 - 2028 |
Base Year (for Immunotherapy Drugs Market Size Estimates) | 2021 |
Study Scope |
|
Market Segmentation |
|
Geographical Coverage |
|
Company Coverage |
|
Premium Insights |
|
Market Analysis
This report extensively covers different segments of Global Immunotherapy Drugs Market and provides an in depth analysis (including revenue analysis for both historic and forecast periods) for all the market segments. In this report, the analysis for every market segment is substantiated with relevant data points and, insights that are generated from analysis of these data points (data trends and patterns).
Global Immunotherapy Drugs Market Analysis
In this report, the Global Immunotherapy Drugs Market has been segmented by Drug Type, Therapy Area, End User and Geography.
Global Immunotherapy Drugs Market, Segmentation by Drug Type
The Global Immunotherapy Drugs Market has been segmented by Drug Type into Monoclonal Antibodies, Adult Vaccines, Checkpoint Inhibitors, Interferons Alpha & Beta, Interleukins and Other Drugs. The complete Global Immunotherapy Drugs Market segmentation by Drug Type can be seen below:
- Global Immunotherapy Drugs Market, By Drug Type
- Monoclonal Antibodies
- Adult Vaccines
- Preventive Vaccines
- Therapeutic Vaccines
- Checkpoint Inhibitors
- Interferons Alpha & Beta
- Interleukins
- Other Drugs
This report provides market size in USD Million and Year on Year (YOY) growth analysis for all the Drug Types mentioned above for historic (2018 - 2021) and forecast (2022 - 2028) periods with 2021 considered as the base year.
The report also provides an analysis of why the market size of the various segments by Drug Type is increasing or decreasing with time along with the reasons for changes in the YOY growth with time.
Immunotherapy drugs have been approved to treat many types of cancer. However, immunotherapy is not yet as widely used as surgery, chemotherapy, or radiation therapy which helps in cancer cure market.
Global Immunotherapy Drugs Market, by Drug Type (USD Million), 2018 - 2028
# | Monoclonal Antibodies | Adult Vaccines | Checkpoint Inhibitors | Interferons Alpha & Beta | Interleukins | Other Drugs |
---|---|---|---|---|---|---|
2018 | 89.1 | 88.7 | 71.3 | 65.5 | 90.4 | 56.2 |
2019 | 93.2 | 104.4 | 72.9 | 69.8 | 98.6 | 63.1 |
2020 | 109.7 | 105.6 | 86.8 | 78.7 | 100.1 | 66.3 |
2021 | 114.0 | 119.9 | 104.0 | 81.5 | 119.8 | 74.4 |
2022 | 132.3 | 138.0 | 113.9 | 94.5 | 130.4 | 78.3 |
2023 | 140.6 | 158.0 | 117.9 | 104.3 | 148.0 | 84.3 |
2024 | 166.7 | 172.8 | 125.8 | 110.2 | 173.1 | 95.6 |
2025 | 188.5 | 179.3 | 140.6 | 125.6 | 184.3 | 111.2 |
2026 | 201.5 | 211.0 | 142.2 | 138.5 | 208.1 | 130.3 |
2027 | 202.2 | 222.3 | 163.5 | 153.9 | 208.2 | 136.0 |
2028 | 220.3 | 232.2 | 178.7 | 181.8 | 216.7 | 162.5 |
Global Immunotherapy Drugs Market, Segmentation by Therapy Area
The Global Immunotherapy Drugs Market has been segmented by Therapy Area into Cancer, Autoimmune and Inflammatory Diseases, Infectious Diseases and Other Therapy Areas. The complete Global Immunotherapy Drugs Market segmentation by Therapy Area can be seen below:
- Global Immunotherapy Drugs Market, By Therapy Area
- Cancer
- Autoimmune and Inflammatory Diseases
- Infectious Diseases
- Other Therapy Areas
This report provides market size in USD Million and Year on Year (YOY) growth analysis for all the Therapy Areas mentioned above for historic (2018 - 2021) and forecast (2022 - 2028) periods with 2021 considered as the base year.
The report also provides an analysis of why the market size of the various segments by Therapy Area is increasing or decreasing with time along with the reasons for changes in the YOY growth with time.
Global Immunotherapy Drugs Market, by Therapy Area (USD Million), 2018 - 2028
# | Cancer | Autoimmune and Inflammatory Diseases | Infectious Diseases | Other Therapy Areas |
---|---|---|---|---|
2018 | 64.1 | 92.0 | 87.4 | 105.4 |
2019 | 68.3 | 107.1 | 94.8 | 123.3 |
2020 | 71.9 | 107.6 | 98.7 | 141.4 |
2021 | 79.2 | 121.3 | 100.4 | 169.7 |
2022 | 89.7 | 121.6 | 108.5 | 184.2 |
2023 | 104.8 | 130.4 | 123.3 | 219.9 |
2024 | 106.4 | 146.4 | 123.8 | 245.5 |
2025 | 124.3 | 166.9 | 130.9 | 293.4 |
2026 | 128.1 | 199.9 | 139.1 | 313.7 |
2027 | 147.3 | 222.6 | 143.7 | 351.4 |
2028 | 150.5 | 254.6 | 170.3 | 404.3 |
Global Immunotherapy Drugs Market, Segmentation by End User
The Global Immunotherapy Drugs Market has been segmented by End User into Hospitals, Clinics and Other End Users. The complete Global Immunotherapy Drugs Market segmentation by End User can be seen below:
- Global Immunotherapy Drugs Market, By End User
- Hospitals
- Clinics
- Other End Users
This report provides market size in USD Million and Year on Year (YOY) growth analysis for all the End Users mentioned above for historic (2018 - 2021) and forecast (2022 - 2028) periods with 2021 considered as the base year.
The report also provides an analysis of why the market size of the various segments by End User is increasing or decreasing with time along with the reasons for changes in the YOY growth with time.
Global Immunotherapy Drugs Market, by End User (USD Million), 2018 - 2028
# | Hospitals | Clinics | Other End Users |
---|---|---|---|
2018 | 108.4 | 77.6 | 83.4 |
2019 | 110.1 | 84.1 | 91.6 |
2020 | 128.8 | 84.4 | 108.9 |
2021 | 128.9 | 93.0 | 113.7 |
2022 | 132.0 | 94.2 | 117.9 |
2023 | 144.4 | 105.4 | 126.3 |
2024 | 150.6 | 123.1 | 136.7 |
2025 | 168.4 | 137.1 | 148.0 |
2026 | 200.6 | 153.3 | 167.5 |
2027 | 235.1 | 168.7 | 174.1 |
2028 | 277.1 | 190.7 | 208.6 |
Global Immunotherapy Drugs Market, Segmentation by Geography
In this report, the Global Immunotherapy Drugs Market has been segmented by Geography into five regions; North America, Europe, Asia Pacific, Middle East and Africa and Latin America.
Global Immunotherapy Drugs Market Share (%), by Geographical Region, 2021
North America | Europe | Asia Pacific | Middle East & Africa | Latin America |
---|---|---|---|---|
20 | 10 | 15 | 5 | 50 |
Find below the list of Countries covered in each of the aforementioned geographical regions:
North America - United States, Canada and Mexico
Latin America - Brazil, Argentina and Rest of Latin America
Europe - Germany, United Kingdom, France, Italy, Spain and Rest of Europe
Asia Pacific - Japan, China, India, Australia & New Zealand, South Korea, ASEAN (Association of South East Asian Nations) and Rest of Asia Pacific
Middle East & Africa - GCC Countries, Egypt, Israel, South Africa, Rest of Middle East & Africa
This report provides market size in USD Million and Year on Year (YOY) percentage growth analysis for the Immunotherapy Drugs Market in all the Regions and Countries (specified above) for historic (2018 - 2021) and forecast (2022 - 2028) Periods with 2021 considered as the base year.
This report also provides an analysis of why the market size of Immunotherapy Drugs in various regions and countries is increasing or decreasing with time along with the reasons for changes in the YOY growth with time.
Market Dynamics
This report provides an in depth analysis of various factors that impact the dynamics of Global Immunotherapy Drugs Market. These factors include; Market Drivers, Restraints and Opportunities Analysis, Market Opportunity Mapping, PEST (Political, Economic, Social and Technological) Analysis and Porter's Five Forces Analysis.
Drivers, Restraints and Opportunity Analysis
- The growth of the Global Immunotherapy Drugs Market is driven by; Increasing Adoption of Targeted Therapy Over Traditional Therapy, Emergence of Biosimilars, Increasing Demand for Mabs, High Prevalence Rate of Lifestyle Diseases and Fast Track and Orphan Drug Designations.
- While the growth of Global Immunotherapy Drugs Market is currently hindered by; High Cost of Immunotherapy Treatment and High Attrition Rate in the Product Development Cycle.
- The new opportunities in Global Immunotherapy Drugs Market will be discussed in detail in the full report.
- Increasing Adoption of Targeted Therapy Over Traditional Therapy.
- Emergence of Biosimilars.
- Increasing Demand for Mabs.
- High Prevalence Rate of Lifestyle Diseases.
- Fast Track and Orphan Drug Designations.
- High Cost of Immunotherapy Treatment.
- High Attrition Rate in the Product Development Cycle.
- Global Immunotherapy Drugs Market Opportunities will be discussed in detail in the full report.
Market Opportunity Map
This report provides market opportunity map for Immunotherapy Drugs Market. The opportunity map (by market segments; Drug Type, Therapy Area and End User) is calculated based on current year market estimates, CAGR and collective revenue over the forecast period. Since, CAGR has been estimated considering all the factors impacting the market; starting from the company's presence, buyer behaviour, to government interference or support. The opportunity map inherently considers all the aforementioned factors impacting the market. The bubble size reflects the estimated opportunity for a particular segment or region, therefore, bigger the bubble size, larger the opportunity.
Global Immunotherapy Drugs Market, Opportunity Map, By Region (2018 - 2028)
North America | Europe | Asia Pacific | Middle East & Africa | Latin America |
---|---|---|---|---|
20 | 10 | 15 | 5 | 50 |
PEST (Political, Economic, Social and Technological) Analysis
This report provides PEST analysis of Immunotherapy Drugs Market. Various factors such as government interference in the market such as regulations (which include but are not limited to pricing and intellectual property policies) that might impact the market are analysed.
This report also provides an analysis of Economic factors affecting the market such as; purchasing power, which directly influences the market growth.
This report also provides an analysis of social factors such as social norms or cultural beliefs inhibiting or promoting the growth of the market
As part of PEST analysis, this report also provides analysis of the impact of Technological factors on growth or decline of a market.
- In depth analysis and insights about the impact of political factors on this market will be provided in the final report.
- In depth analysis and insights about the impact of economic factors on this market will be provided in the final report.
- In depth analysis and insights about the impact of social factors on this market will be provided in the final report.
- In depth analysis and insights about the impact of technological factors on this market will be provided in the final report.
Porter's Five Force Analysis
This report provides Porter's Five Forces analysis of Global Immunotherapy Drugs Market, which include; Bargaining Power of Suppliers, Bargaining Power of Buyers, Threat of New Entrants, Threat of Substitutes and Competitive Rivalry.
Bargaining Power of Suppliers:
Various factors such as; Supplier Switching Costs Relative to Firm Switching Costs, Supplier Competition and Possibility of Forward Integration, Presence of Substitute Inputs, Strength of Distribution Channels, and Supplier Concentration to Firm Concentration Ratio would be analysed to estimate bargaining power of suppliers in the Global Immunotherapy Drugs Market. Bargaining power of suppliers will be reported on a scale of 0-10 with 0 being the lowest value and 10 being the highest value.
Bargaining Power of Suppliers
Supplier Switching Costs Relative To Firm Switching Costs | Strength of Distribution Channels | Supplier Concentration to firm Concentration Ratio | Presence of Substitute Inputs | Supplier Competition and Possibly of Forward Integration |
---|---|---|---|---|
20 | 10 | 15 | 5 | 50 |
Bargaining Power of Buyers:
Various factors such as; Buyer Concentration to Firm Concentration Ratio, Buyer Switching Costs, Availability of Existing Substitute Products, Buyer Price Sensitivity, and Degree of Dependency upon Existing Channels of Distribution would be analysed to estimate bargaining power of buyers in the Global Immunotherapy Drugs Market. Bargaining power of buyers will be reported on a scale of 0-10 with 0 being the lowest value and 10 being the highest value.
Bargaining Power of Buyers
Buyer Competition to Firm Concentration Ratio | Buyer Switching Costs | Availability of existing Substitute Products | Buyer Price Sensitivity | Degree of Dependency upon Existing Channels of Distribution |
---|---|---|---|---|
10 | 15 | 25 | 45 | 32 |
Threat of Substitutes:
Various factors such as; Availability of Substitutes, Number of Available Substitutes, Price of Substitute Products, Buyer Switching Costs, and Buyer Propensity to Substitute would be analysed to estimate threat of substitutes in the Global Immunotherapy Drugs Market. Threat of substitutes will be reported on a scale of 0-10 with 0 being the lowest value and 10 being the highest value.
Threat of Substitutes:
Availability of Substitutes | Number of Available Substitutes | Price of Substitute Products | Buyer Switching Costs | Buyer Propensity to Substitute |
---|---|---|---|---|
20 | 35 | 10 | 2 | 5 |
Threat of New Entrants:
Various factors such as; Barriers to Entry, Economies of Scale, Product Differentiation, Customer Loyalty, Network Effect, and Access to Distribution Channels would be analysed to estimate threat of new entrants in the Global Immunotherapy Drugs Market. Threat of new entrants will be reported on a scale of 0-10 with 0 being the lowest value and 10 being the highest value.
Threat of New Entrants:
Barriers to entry | Economics of scale | Product Differentiation | Customer Loyalty | Network Effect | Access to Ditribution Channels |
---|---|---|---|---|---|
2 | 35 | 25 | 10 | 15 | 55 |
Competitive Rivalry:
Various factors such as; Firm concentration Ratio, Level of Advertising Expense, Sustainable Competitive Advantage through Innovation, Competitive Strategy and Degree of Transparency would be analysed to estimate competitive rivalry in the Global Immunotherapy Drugs Market. Competitive rivalry will be reported on a scale of 0-10 with 0 being the lowest value and 10 being the highest value.
Industry Rivalry:
Firm Concentration Ratio | Level of Advertising Expense | Sustainable Competitive Adavantage through Innovation | Degree of Transparency | Competitive strategy |
---|---|---|---|---|
5 | 10 | 15 | 35 | 45 |
Competitive Landscape Analysis
Key players in Global Immunotherapy Drugs Market include, F. Hoffmann-La Roche AG, Merck & Co., Inc., Novartis International AG, Johnson & Johnson (A Parent Company of Janssen Biotech, Inc.), Glaxosmithkline PLC, Amgen Inc., Abbvie, Astrazeneca, Bristol-Myers Squibb and ELI Lilly and Company.
In this report, the profile of each market player provides following information:
- Company Overview and Product Portfolio
- Key Developments
- Financial Overview
- Strategies
- Company SWOT Analysis
Company SWOT Analysis
This report also provides Heat map analysis of Products/Services Offered by different companies operating in this market.
Competitors Products/Services Heat Map Analysis
Company Vs. Product/Service | Company 1 | Company 2 | Company 3 | Company 4 | Company 5 | Company 6 | Company 7 | Company 8 | Company 9 | Company 10 |
---|---|---|---|---|---|---|---|---|---|---|
Product 1/Service 1 | ||||||||||
Product 2/Service 2 | ||||||||||
Product 3/Service 3 | ||||||||||
Product 4/Service 4 | ||||||||||
Product 5/Service 5 | ||||||||||
Product 6/Service 6 | ||||||||||
Product 7/Service 7 | ||||||||||
Product 8/Service 8 |
- Introduction
- Research Objectives and Assumptions
- Research Methodology
- Abbreviations
- Market Definition & Study Scope
- Executive Summary
- Market Snapshot, By Drug Type
- Market Snapshot, By Therapy Area
- Market Snapshot, By End User
- Market Snapshot, By Region
- Market Opportunity Map
- Global Immunotherapy Drugs Market Dynamics
- Drivers, Restraints and Opportunities
- Drivers
- Increasing Adoption of Targeted Therapy Over Traditional Therapy
- Emergence of Biosimilars
- Increasing Demand for Mabs
- High Prevalence Rate of Lifestyle Diseases
- Fast Track and Orphan Drug Designations
- Restraints
- High Cost of Immunotherapy Treatment
- High Attrition Rate in the Product Development Cycle
- Opportunities
- Drivers
- Regulatory Scenario
- Pipeline Analysis/Technological Advancements
- PEST Analysis
- Political Analysis
- Economic Analysis
- Social Analysis
- Technological Analysis
- Porter's Analysis
- Bargaining Power of Suppliers
- Bragaining Power of Buyers
- Threat of Substitutes
- Threat of New Entrants
- Industry Rivalry
- Drivers, Restraints and Opportunities
- Market Segmentation
- Global Immunotherapy Drugs Market, By Drug Type, 2018 - 2028 (USD Million)
- Introduction
- Market Share Analysis, 2022 and 2028 (%)
- Y-o-Y Growth Analysis, 2019 - 2028
- Segment Trends
- Monoclonal Antibodies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018 - 2028 (USD Million)
- Adult Vaccines
- Introduction
- Market Share Analysis, 2022 and 2028 (%)
- Y-o-Y Growth Analysis, 2019 - 2028
- Segment Trends
- Preventive Vaccines
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018 - 2028 (USD Million)
- Therapeutic Vaccines
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018 - 2028 (USD Million)
- Preventive Vaccines
- Checkpoint Inhibitors
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018 - 2028 (USD Million)
- Interferons Alpha & Beta
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018 - 2028 (USD Million)
- Interleukins
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018 - 2028 (USD Million)
- Other Drugs
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018 - 2028 (USD Million)
- Monoclonal Antibodies
- Global Immunotherapy Drugs Market, By Therapy Area, 2018 - 2028 (USD Million)
- Introduction
- Market Share Analysis, 2022 and 2028 (%)
- Y-o-Y Growth Analysis, 2019 - 2028
- Segment Trends
- Cancer
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018 - 2028 (USD Million)
- Autoimmune and Inflammatory Diseases
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018 - 2028 (USD Million)
- Infectious Diseases
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018 - 2028 (USD Million)
- Other Therapy Areas
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018 - 2028 (USD Million)
- Cancer
- Global Immunotherapy Drugs Market, By End User, 2018 - 2028 (USD Million)
- Introduction
- Market Share Analysis, 2022 and 2028 (%)
- Y-o-Y Growth Analysis, 2019 - 2028
- Segment Trends
- Hospitals
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018 - 2028 (USD Million)
- Clinics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018 - 2028 (USD Million)
- Other End Users
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018 - 2028 (USD Million)
- Hospitals
- Global Immunotherapy Drugs Market, By Geography, 2018 - 2028 (USD Million)
- Introduction
- Market Share Analysis, 2022 and 2028 (%)
- Y-o-Y Growth Analysis, 2019 - 2028
- Regional Trends
- North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2018 - 2028 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Therapy Area, 2018 - 2028 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2018 - 2028 (USD Million)
- United States
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2018 - 2028 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Therapy Area, 2018 - 2028 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2018 - 2028 (USD Million)
- Canada
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2018 - 2028 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Therapy Area, 2018 - 2028 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2018 - 2028 (USD Million)
- United States
- Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2018 - 2028 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Therapy Area, 2018 - 2028 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2018 - 2028 (USD Million)
- Germany
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2018 - 2028 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Therapy Area, 2018 - 2028 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2018 - 2028 (USD Million)
- United Kingdom
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2018 - 2028 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Therapy Area, 2018 - 2028 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2018 - 2028 (USD Million)
- France
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2018 - 2028 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Therapy Area, 2018 - 2028 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2018 - 2028 (USD Million)
- Italy
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2018 - 2028 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Therapy Area, 2018 - 2028 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2018 - 2028 (USD Million)
- Spain
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2018 - 2028 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Therapy Area, 2018 - 2028 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2018 - 2028 (USD Million)
- Rest of Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2018 - 2028 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Therapy Area, 2018 - 2028 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2018 - 2028 (USD Million)
- Germany
- Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2018 - 2028 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Therapy Area, 2018 - 2028 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2018 - 2028 (USD Million)
- Japan
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2018 - 2028 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Therapy Area, 2018 - 2028 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2018 - 2028 (USD Million)
- China
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2018 - 2028 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Therapy Area, 2018 - 2028 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2018 - 2028 (USD Million)
- India
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2018 - 2028 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Therapy Area, 2018 - 2028 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2018 - 2028 (USD Million)
- Australia & New Zealand
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2018 - 2028 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Therapy Area, 2018 - 2028 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2018 - 2028 (USD Million)
- South Korea
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2018 - 2028 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Therapy Area, 2018 - 2028 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2018 - 2028 (USD Million)
- ASEAN (Association of South East Asian Countries)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2018 - 2028 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Therapy Area, 2018 - 2028 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2018 - 2028 (USD Million)
- Rest of Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2018 - 2028 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Therapy Area, 2018 - 2028 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2018 - 2028 (USD Million)
- Japan
- Middle East & Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2018 - 2028 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Therapy Area, 2018 - 2028 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2018 - 2028 (USD Million)
- GCC
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2018 - 2028 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Therapy Area, 2018 - 2028 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2018 - 2028 (USD Million)
- Israel
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2018 - 2028 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Therapy Area, 2018 - 2028 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2018 - 2028 (USD Million)
- South Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2018 - 2028 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Therapy Area, 2018 - 2028 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2018 - 2028 (USD Million)
- Rest of Middle East & Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2018 - 2028 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Therapy Area, 2018 - 2028 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2018 - 2028 (USD Million)
- GCC
- Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2018 - 2028 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Therapy Area, 2018 - 2028 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2018 - 2028 (USD Million)
- Brazil
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2018 - 2028 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Therapy Area, 2018 - 2028 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2018 - 2028 (USD Million)
- Mexico
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2018 - 2028 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Therapy Area, 2018 - 2028 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2018 - 2028 (USD Million)
- Argentina
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2018 - 2028 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Therapy Area, 2018 - 2028 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2018 - 2028 (USD Million)
- Rest of Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2018 - 2028 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Therapy Area, 2018 - 2028 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2018 - 2028 (USD Million)
- Brazil
- North America
- Global Immunotherapy Drugs Market, By Drug Type, 2018 - 2028 (USD Million)
- Competitive Landscape
- Heat Map Analysis
- Company Profiles
- F. Hoffmann-La Roche AG
- Company Overview and Product Portfolio
- Key Developments
- Financial Overview
- Strategies
- Company SWOT Analysis
- Merck & Co., Inc.
- Company Overview and Product Portfolio
- Key Developments
- Financial Overview
- Strategies
- Company SWOT Analysis
- Novartis International AG
- Company Overview and Product Portfolio
- Key Developments
- Financial Overview
- Strategies
- Company SWOT Analysis
- Johnson & Johnson (A Parent Company of Janssen Biotech, Inc.)
- Company Overview and Product Portfolio
- Key Developments
- Financial Overview
- Strategies
- Company SWOT Analysis
- Glaxosmithkline PLC
- Company Overview and Product Portfolio
- Key Developments
- Financial Overview
- Strategies
- Company SWOT Analysis
- Amgen Inc.
- Company Overview and Product Portfolio
- Key Developments
- Financial Overview
- Strategies
- Company SWOT Analysis
- Abbvie
- Company Overview and Product Portfolio
- Key Developments
- Financial Overview
- Strategies
- Company SWOT Analysis
- Astrazeneca
- Company Overview and Product Portfolio
- Key Developments
- Financial Overview
- Strategies
- Company SWOT Analysis
- Bristol-Myers Squibb
- Company Overview and Product Portfolio
- Key Developments
- Financial Overview
- Strategies
- Company SWOT Analysis
- ELI Lilly and Company
- Company Overview and Product Portfolio
- Key Developments
- Financial Overview
- Strategies
- Company SWOT Analysis
- F. Hoffmann-La Roche AG
- Analyst Views
- Future Outlook of the Market
ReAnIn's Most Viewed Titles:
In the year 2021, the Global Implantable Cardiac Pacemakers Market was valued at USD xx.x million. The size of this market is expected to increase to USD xx.x million by the year 2028, while growing at a Compounded Annual Growth Rate (CAGR) of x.x%
In the year 2021, the Global Implantable Drug Delivery Devices Market was valued at USD xx.x million. The size of this market is expected to increase to USD xx.x million by the year 2028, while growing at a Compounded Annual Growth Rate (CAGR) of x.x%
In the year 2021, the Global Implantable Medical Devices Market was valued at USD xx.x million. The size of this market is expected to increase to USD xx.x million by the year 2028, while growing at a Compounded Annual Growth Rate (CAGR) of x.x%
In the year 2021, the Global In Situ Hybridization (ISH) Market was valued at USD xx.x million. The size of this market is expected to increase to USD xx.x million by the year 2028, while growing at a Compounded Annual Growth Rate (CAGR) of x.x%